Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
  • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/415—1,2-Diazoles
  • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/415—1,2-Diazoles
  • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/04—Centrally acting analgesics, e.g. opioids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P9/00—Drugs for disorders of the cardiovascular system
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
  • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
  • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
  • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
  • C07D231/18—One oxygen or sulfur atom
  • C07D231/20—One oxygen atom attached in position 3 or 5
  • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Medicinal Chemistry (AREA)
• Animal Behavior & Ethology (AREA)
• Life Sciences & Earth Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Epidemiology (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• General Chemical & Material Sciences (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Biomedical Technology (AREA)
• Pain & Pain Management (AREA)
• Neurology (AREA)
• Neurosurgery (AREA)
• Heart & Thoracic Surgery (AREA)
• Cardiology (AREA)
• Rheumatology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Applications Claiming Priority (4)

Publications (1)

Family

ID=43897079

Family Applications (1)

Country Status (32)

Families Citing this family (18)

Family Cites Families (6)

• 2011
  • 2011-02-04 SG SG2012053724A patent/SG182628A1/en unknown
  • 2011-02-04 KR KR1020127023081A patent/KR20120123532A/ko not_active Ceased
  • 2011-02-04 KR KR1020187015725A patent/KR20180063379A/ko not_active Ceased
  • 2011-02-04 AR ARP110100380A patent/AR080133A1/es unknown
  • 2011-02-04 US US15/616,347 patent/USRE47214E1/en active Active
  • 2011-02-04 PT PT117020560T patent/PT2531177T/pt unknown
  • 2011-02-04 CA CA2788024A patent/CA2788024C/en not_active Expired - Fee Related
  • 2011-02-04 RU RU2012137495/04A patent/RU2560150C2/ru not_active IP Right Cessation
  • 2011-02-04 EP EP11702056.0A patent/EP2531177B8/en active Active
  • 2011-02-04 JP JP2012551631A patent/JP5894086B2/ja active Active
  • 2011-02-04 MX MX2012009018A patent/MX339193B/es active IP Right Grant
  • 2011-02-04 HU HUE11702056A patent/HUE029738T2/en unknown
  • 2011-02-04 ES ES11702056.0T patent/ES2586212T3/es active Active
  • 2011-02-04 NZ NZ601316A patent/NZ601316A/en not_active IP Right Cessation
  • 2011-02-04 ME MEP-2016-154A patent/ME02483B/me unknown
  • 2011-02-04 SI SI201130895A patent/SI2531177T1/sl unknown
  • 2011-02-04 RS RS20160612A patent/RS55046B1/sr unknown
  • 2011-02-04 MA MA35183A patent/MA34047B1/fr unknown
  • 2011-02-04 US US13/577,078 patent/US9051275B2/en not_active Ceased
  • 2011-02-04 AU AU2011212476A patent/AU2011212476B2/en not_active Ceased
  • 2011-02-04 SG SG10201500832PA patent/SG10201500832PA/en unknown
  • 2011-02-04 HR HRP20160937TT patent/HRP20160937T1/hr unknown
  • 2011-02-04 PH PH1/2012/501510A patent/PH12012501510A1/en unknown
  • 2011-02-04 DK DK11702056.0T patent/DK2531177T3/en active
  • 2011-02-04 BR BR112012018958A patent/BR112012018958A8/pt not_active Application Discontinuation
  • 2011-02-04 CN CN201180008354.5A patent/CN102753155B/zh active Active
  • 2011-02-04 WO PCT/EP2011/051630 patent/WO2011095579A1/en not_active Ceased
  • 2011-02-04 PL PL11702056.0T patent/PL2531177T3/pl unknown
  • 2011-02-08 TW TW100104115A patent/TWI568729B/zh not_active IP Right Cessation
• 2012
  • 2012-07-04 TN TNP2012000347A patent/TN2012000347A1/en unknown
  • 2012-07-13 EC ECSP12012039 patent/ECSP12012039A/es unknown
  • 2012-08-02 IL IL221277A patent/IL221277A/en not_active IP Right Cessation
  • 2012-09-04 CO CO12151303A patent/CO6592093A2/es not_active Application Discontinuation
• 2016
  • 2016-08-04 SM SM201600264T patent/SMT201600264B/it unknown
  • 2016-08-08 CY CY20161100779T patent/CY1117886T1/el unknown

Also Published As

Similar Documents